These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20818681)

  • 1. [Plectasin - a new peptide antibiotic with high therapeutic potential].
    Schmitz J; Holzgrabe U
    Pharm Unserer Zeit; 2010 Sep; 39(5):336-8. PubMed ID: 20818681
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel antimicrobial peptides that exhibit activity against select agents and other drug resistant bacteria.
    Venugopal D; Klapper D; Srouji AH; Bhonsle JB; Borschel R; Mueller A; Russell AL; Williams BC; Hicks RP
    Bioorg Med Chem; 2010 Jul; 18(14):5137-47. PubMed ID: 20558071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodology of prevention of antibiotic resistance.
    Shetty A
    J Assoc Physicians India; 2010 Dec; 58 Suppl():47-8. PubMed ID: 21568010
    [No Abstract]   [Full Text] [Related]  

  • 4. What is inadequate antibacterial therapy?
    Moellering RC
    Clin Infect Dis; 2009 Oct; 49(7):1006-8. PubMed ID: 19719418
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oxazolidinones. A new anti-infective principle].
    Roloff T; Holtfoht A; Ziegler A; Heinzl S
    Med Monatsschr Pharm; 1999 Dec; 22(12):370-5. PubMed ID: 10628146
    [No Abstract]   [Full Text] [Related]  

  • 6. [The antibiotic sensitivity test in urinary tract infections; limitations and interpretational criteria].
    G Batteriol Virol Immunol; 1978; 71(7-12):207-74. PubMed ID: 549570
    [No Abstract]   [Full Text] [Related]  

  • 7. Doripenem: an early look at a carbapenem not yet approved for pediatrics.
    Overturf GD
    Pediatr Infect Dis J; 2010 Feb; 29(2):163-5. PubMed ID: 20135831
    [No Abstract]   [Full Text] [Related]  

  • 8. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus.
    Mygind PH; Fischer RL; Schnorr KM; Hansen MT; Sönksen CP; Ludvigsen S; Raventós D; Buskov S; Christensen B; De Maria L; Taboureau O; Yaver D; Elvig-Jørgensen SG; Sørensen MV; Christensen BE; Kjaerulff S; Frimodt-Moller N; Lehrer RI; Zasloff M; Kristensen HH
    Nature; 2005 Oct; 437(7061):975-80. PubMed ID: 16222292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case studies of bacterial species responsible for urinary tract infections and their sensitivity to antibiotic treatment].
    Dominici C; Morozzi B
    Minerva Chir; 1978 Dec 15-31; 33(23-24):1745-62. PubMed ID: 740260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is antibiotic therapy the absolute weapon against infection? Some errors to be avoided in therapy.
    Sureau B; Berrod J
    Mater Med Pol; 1974; 6(1):69-76. PubMed ID: 4498154
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotics of choice for clinically important bacteria.
    Jeljaszewicz J
    Adv Clin Pharmacol; 1974; 8():89-95. PubMed ID: 4468734
    [No Abstract]   [Full Text] [Related]  

  • 12. [The choice of an antibiotic].
    Sala G
    Minerva Med; 1975 Nov; 66(80):4212-6. PubMed ID: 1196513
    [No Abstract]   [Full Text] [Related]  

  • 13. Natures antibiotics: the potential of antimicrobial peptides as new drugs.
    Diamond G
    Biologist (London); 2001 Oct; 48(5):209-12. PubMed ID: 11584134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic activity and synergistic effect of antimicrobial peptide against pathogens from a patient with gallstones.
    Park Y; Park SN; Park SC; Park JY; Park YH; Hahm JS; Hahm KS
    Biochem Biophys Res Commun; 2004 Aug; 321(3):631-7. PubMed ID: 15358153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rational approach to the selection of an antimicrobial agent.
    Hirsh DC; Ruehl WW
    J Am Vet Med Assoc; 1984 Nov; 185(10):1058-61. PubMed ID: 6392230
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial peptides: new candidates in the fight against bacterial infections.
    Toke O
    Biopolymers; 2005; 80(6):717-35. PubMed ID: 15880793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The possibilities for the bacteriology laboratory in guiding antibiotic therapy].
    Turcu T
    Rev Med Chir Soc Med Nat Iasi; 1988; Suppl():51-6. PubMed ID: 3253912
    [No Abstract]   [Full Text] [Related]  

  • 18. [Infections through gram positive bacteria].
    Mendoza-Hernández P
    Gac Med Mex; 1975 Jul; 110(1):70-4. PubMed ID: 1149997
    [No Abstract]   [Full Text] [Related]  

  • 19. [Infections through gram-negative bacteria].
    Ruiloba J
    Gac Med Mex; 1975 Jul; 110(1):66-9. PubMed ID: 1149996
    [No Abstract]   [Full Text] [Related]  

  • 20. Dermcidin: what is its antibiotic potential?
    Zeth K
    Future Microbiol; 2013 Jul; 8(7):817-9. PubMed ID: 23841626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.